Li He

Davis Polk advised Genetron Holdings Limited on its SEC-registered initial public offering of 16,000,000 American Depositary Shares. Each ADS represents five ordinary shares. Genetron has…

Davis Polk advised the underwriters in the secondary listing and initial public offering of NetEase, Inc. on the Hong Kong Stock Exchange. The gross proceeds from the global offering…

Davis Polk advised Kingsoft Cloud Holdings Limited on its SEC-registered initial public offering of 30,000,000 American Depositary Shares for total proceeds of approximately $510 million…

Davis Polk advised the underwriters in the initial public offering and listing on the Hong Kong Stock Exchange and the international offering in reliance on Rule 144A and Regulation S…

Davis Polk advised InnoCare Pharma Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule 144A…

Davis Polk advised the underwriters on the SEC-registered initial public offering by I-Mab of 7,407,400 American depositary shares, each 10 ADSs representing 23 ordinary shares, for total…

Davis Polk advised LIZHI INC. on its SEC-registered initial public offering of 4,100,000 American depositary shares for total proceeds of approximately $45.1 million if the underwriters do…

Davis Polk advised the lead underwriters on the SEC-registered initial public offering by Molecular Data Inc. of 11,500,000 American Depositary Shares sold by Molecular Data, for gross…

Davis Polk advised Venus Medtech (Hangzhou) Inc. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule…

Davis Polk advised the underwriters on the SEC-registered initial public offering by ECMOHO Limited of 4,375,000 American Depositary Shares for gross proceeds of $43.8 million. Each ADS…